Good morning, one and all. Damian Garde here, filling in for Ed Silverman on an rain-sodden morning that promises only to amplify those daydreams of weekend respite. May your day of meetings, deadlines, and sundry workplace indignities pass quickly, and may the following tidbits speed you on your path. And, as always, do let us know if you hear anything particularly saucy out there.

Several former Roche (ROG) employees and other individuals are being investigated by police in St. Petersburg, Russia, for allegedly stealing and then reselling MabThera, which is also known as Rituxan, on the black market, Crime Russia dishes. The police seized documents indicating payments were made to doctors who wrote prescriptions for large quantities of the medicine. A spokesperson for the drug maker tells us the employees were no longer working at the company as of 2014 and that the company is “fully collaborating with the authorities.”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy